Nicole Germino

Stock Analyst at Truist Securities

(3.69)
# 801
Out of 5,045 analysts
23
Total ratings
65%
Success rate
34.02%
Average return
Main Sectors:

Stocks Rated by Nicole Germino

Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $126$139
Current: $188.78
Upside: -26.37%
Perspective Therapeutics
May 14, 2025
Maintains: Buy
Price Target: $10$8
Current: $2.72
Upside: +194.66%
Sangamo Therapeutics
Jan 23, 2025
Maintains: Buy
Price Target: $7$5
Current: $0.59
Upside: +752.66%
Assembly Biosciences
Oct 24, 2022
Downgrades: Hold
Price Target: $132$24
Current: $31.02
Upside: -22.63%
Forte Biosciences
Sep 3, 2021
Downgrades: Hold
Price Target: n/a
Current: $14.20
Upside: -